Grifols S.A.

Symbol: GRFS     Sector: Healthcare     Industry: Drug Manufacturers

Dividend Yield
1.19%
Current Price
$22.10
Info     Dividend Rate History     Earnings     Financials     Rankings

Financials 2018

Update: 2019-06-09 13:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
1,222,806,000
1,222,806,000
704,768,000
518,038,000
296,923,000
221,115,000
128,345,000
3,483,251,000
12,477,046,000
7,780,442,000
4,225,554,000
1,033,792,000
268,199,000
1,033,792,000
6,288,707,000
441,912,000
328,682,000
 
70,180,000

Q 3

2018-09-30
1,143,800,000
1,143,800,000
618,538,000
525,262,000
258,495,000
266,767,000
149,318,000
3,024,376,000
11,779,675,000
7,632,305,000
4,145,026,000
582,008,000
-
633,400,000
-
-92,515,000
159,561,000
 
58,234,000

Q 2

2018-06-30
1,097,106,000
1,097,106,000
579,680,000
517,426,000
255,734,000
261,692,000
175,572,000
2,947,373,000
11,433,619,000
7,462,375,000
3,967,400,000
668,499,000
192,648,000
689,558,000
6,148,533,000
-223,899,000
156,480,000
 
58,281,000

Q 1

2018-03-31
1,023,012,000
1,023,012,000
534,178,000
488,834,000
244,284,000
244,550,000
143,407,000
2,965,872,000
10,875,229,000
7,165,384,000
3,705,408,000
846,522,000
174,405,000
857,035,000
-
-17,434,000
92,705,000
 
53,966,000

Financials 2017

Update: 2019-06-09 13:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
1,067,890,000
1,067,890,000
550,424,000
517,466,000
316,623,000
200,843,000
230,937,000
2,945,316,000
10,920,264,000
7,286,299,000
3,629,079,000
886,521,000
133,067,000
886,521,000
11,913,060,000
83,135,000
271,174,000
 
106,436,000